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1122 Letters to the Editor October 2014repair. The latter perhaps may be due to patient preference, clinical
deterioration, or severe comorbid conditions that preclude survival
even with attempted repair.
We believe that the transfer process for rAAA can be improved
to ensure optimal outcomes with efﬁcient utilization of resources.
Potential strategies include improvements in the transfer process,
as outlined by Dr Altreuther, as well as improved guidelines to
identify patients whose survival is unlikely and for whom care mea-
sures other than transfer may be considered.
Matthew Mell, MD
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Regarding “Prospective, randomized study of cutting
balloon angioplasty versus conventional balloon
angioplasty for the treatment of hemodialysis access
stenoses”
In their recently reported randomized trial, Saleh et al found
that cutting balloon angioplasty improved treatment area pri-
mary patency of graft-vein anastomotic lesions at 6 and 12
months compared with conventional balloon angioplasty.1 How-
ever, for lesions at other locations treated with cutting balloons,
there was no beneﬁt over conventional angioplasty. We believe
the study has several important limitations that require further
discussion.
The study included both native arteriovenous ﬁstulas (AVFs)
and prosthetic grafts, but it is well established that prosthetic grafts
require more interventions to maintain patency than AVFs do.2
These two scenarios have vastly differing pathologic processes
and outcomes and cannot be grouped as if similar. Reporting
the proportion of native AVFs and grafts in the study and sub-
group analysis separating both types of access would provide addi-
tional important information.
Saleh et al classify lesion location into four categories:
venous, graft-to-vein anastomotic, intragraft, and arterial anasto-
motic. In native AVFs, only two of these categories apply. In such
cases, venous refers to all lesions from the arteriovenous anasto-
mosis to the cephalic arch. The terminal portion of the cephalic
vein is particularly prone to restenosis after conventional angio-
plasty and is, in and of itself, an area of research interest. Obser-
vational studies also suggest that lesion length and angioplasty in
newer AVFs may also be associated with higher rates of resteno-
sis.3 Information on access age, lesion characteristics, and com-
parison of patency at other speciﬁc venous locations might
generate additional hypotheses on the indications for cutting
balloon use.
Cumulative or secondary patency (ie, the time from initial
angioplasty until the access is abandoned) is the most important
outcome for patients as it represents the functional life of the ac-
cess. However, the authors do not report this outcome; instead,
the main patency deﬁnition used is treatment area primary
patency. Reporting access circuit primary patency (ie, the time
from initial angioplasty to repeated endovascular intervention
for any lesion in the access circuit) is mandatory and ultimately
more important than isolated lesion primary patency. Thrombosisleading to access loss is important because of the potential for
exposure of the patient to mortality risk associated with central
venous catheters. Freedom from access interventions is another
important measure of quality of life for hemodialysis patients.
None of these clinically meaningful end points are measured or
reported in the trial.
This study is timely, given the increasingly strong evidence sup-
porting the use of stent grafts in many of these scenarios, such as the
original FLAIR trial and presented results of REVISE and REN-
OVA, all randomized trials demonstrating graft preservation supe-
rior to angioplasty to 2 years.4 One other recent study, by Aftab
et al, suggested the utility of cutting balloon compared with angio-
plasty in AVFs,5 although Vesely and Siegel’s larger trial in pros-
thetic grafts did not.6 Given these mixed messages and limits of
presented data within the current study, we believe that the study
by Saleh et al does not support the widespread use of cutting
balloon angioplasty for dialysis access stenosis.
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Regarding “Management of acute limb ischemia in the
pediatric population”
Peripheral vascular injuries of the lower extremity in the pedi-
atric population are rare but can result in signiﬁcant morbidity.
These injuries are usually iatrogenic after catheterization or inva-
sive monitoring. Pediatric peripheral vascular trauma is far less
frequent, and there is scarcity of reported experience with
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ment has traditionally been based on adult experience; but vascular
injuries of pediatric patients may differ from those of adults in that
signiﬁcant injuries are underdiagnosed because they are more
commonly asymptomatic, are more associated with vasospasm, or
occur with more severe life-threatening injuries that take priority
in the resuscitation process.1
Kayssi et al2 recently described their large series of 151 pe-
diatric vascular injuries secondary to multiple causes, mostly iat-
rogenic injuries. They demonstrated successful outcomes by
using nonoperative management with anticoagulation in most
patients. Although all of their trauma patients underwent oper-
ative intervention, there is no consensus yet regarding the neces-
sity of immediate surgical treatment of all such injuries, especially
in neonates and infants. We recently reported our experience
with 32 pediatric lower extremity traumatic vascular injuries
that underwent deﬁnitive operative repair.3 The greatest con-
cerns with vascular injuries in pediatric patients are restoration
of sufﬁcient circulation and future limb growth with vascular
repair. If minimal vascular injury is present, primary repair
should be the preferred technique. Autologous grafts, such as
reversed saphenous vein, are preferred if primary repair is not
feasible and have demonstrated the best long-term outcomes.4
Synthetic conduits, such as polytetraﬂuoroethylene graft, can
also be successfully used, but they are more prone to infection,
and small-diameter grafts have higher thrombosis rates with
poor long-term patency.5 In our series, both synthetic and autol-
ogous grafts were used more commonly than primary repair. We
advocate that vascular anastomosis be performed with interrup-
ted sutures to accommodate growth patterns in children.
Continuous suture repair may lead to arterial narrowing with
progressive limb growth.
On the basis of our experience, the management of traumatic
lower extremity vascular injuries in pediatric patients requires early
identiﬁcation and prompt surgical intervention in nearly all cases
and can result in acceptable early outcomes. Surgical repair can
be undertaken in older children as in adults, but it may be
extremely challenging in those infants younger than 2.5 years. In
this age group, there is a great potential for rapid growth of
adequate collateral circulation, and conservative management
with anticoagulation may be attempted initially in a nonthreatened
ischemic extremity.6 Such complex lesions should be managed in
tertiary specialized care facilities with a multidisciplinary team
involving trauma and pediatric surgeons and pediatricians. We
look forward to seeing further clinical experience and guidelines
to orient vascular and trauma surgeons in the management of
such complex injuries.
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Surgery Society becomes the Vascular and
Endovascular Surgery SocietyIt is not the strongest or the most intelligent who will survive
but those who can best manage change.dCharles DarwinIf you choose not to decide, you still have made a choice.
dNeil PeartThe name of any professional group should reﬂect the mem-
bership. Thus, after many years of discussion and debate, the
Peripheral Vascular Surgery Society has changed its name to the
Vascular and Endovascular Surgery Society (VESS). This Society
was formulated in 1976 as the Peripheral Vascular Surgery Club
and has grown during 40 years to become a national group
devoted to the young vascular surgeon in his or her ﬁrst 15 years
of practice.
The rationale for changing the name of the Society was based
on multiple elements.
1. Peripheral vascular surgery is considered an outdated term
from the 1970s differentiating cardiac/coronary surgeons from
vascular surgeons.Most currentvascular surgeonsandtraineesperform
plenty of “central” vascular surgery and intervention including
thoracic, abdominal, visceral, and central venous procedures.
2. Peripheral vascular surgery does not match the Board Cer-
tiﬁcation title for our ﬁeld. In the recent era, all American Board of
Surgery certiﬁcates are for Vascular Surgery. In addition, most
practices, academic divisions, and vascular journals do not include
the term peripheral in their title.
3. The public barely understands what a vascular surgeon
does, let alone a “peripheral vascular surgeon.” A consistent and
cohesive name helps build the brand for vascular surgeons. “Pe-
ripheral” connotes something of less importancedcertainly some-
thing we do not want to highlight.
4. Endovascular procedures are becoming a larger component
of our members’ practices.
The process to change the Society name appeared simple but
actually was an arduous task. An ad hoc committee including
the authors of this communication came up with a list of possible
alternative names, performed a SWOT analysis, surveyed the
